These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 24980783)
1. Establishment of CYP2D6 reference samples by multiple validated genotyping platforms. Fang H; Liu X; Ramírez J; Choudhury N; Kubo M; Im HK; Konkashbaev A; Cox NJ; Ratain MJ; Nakamura Y; O'Donnell PH Pharmacogenomics J; 2014 Dec; 14(6):564-72. PubMed ID: 24980783 [TBL] [Abstract][Full Text] [Related]
2. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Zhou SF Clin Pharmacokinet; 2009; 48(12):761-804. PubMed ID: 19902987 [TBL] [Abstract][Full Text] [Related]
3. National Prociency Testing Result of CYP2D6*10 Genotyping for Adjuvant Tamoxifen Therapy in China. Lin G; Zhang K; Yi L; Han Y; Xie J; Li J PLoS One; 2016; 11(9):e0162361. PubMed ID: 27603206 [TBL] [Abstract][Full Text] [Related]
4. The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: a systematic review. Fleeman N; Martin Saborido C; Payne K; Boland A; Dickson R; Dundar Y; Fernández Santander A; Howell S; Newman W; Oyee J; Walley T Health Technol Assess; 2011 Sep; 15(33):1-102. PubMed ID: 21906462 [TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 2C19 enzyme, Cytochrome P450 2C9 enzyme, and Cytochrome P450 2D6 enzyme allelic variants and its possible effect on drug metabolism: A retrospective study. Naujokaitis D; Asmoniene V; Kadusevicius E Medicine (Baltimore); 2021 Mar; 100(11):e24545. PubMed ID: 33725937 [TBL] [Abstract][Full Text] [Related]
6. Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing. Yang Y; Botton MR; Scott ER; Scott SA Pharmacogenomics; 2017 May; 18(7):673-685. PubMed ID: 28470112 [TBL] [Abstract][Full Text] [Related]
7. CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. Jin Y; Desta Z; Stearns V; Ward B; Ho H; Lee KH; Skaar T; Storniolo AM; Li L; Araba A; Blanchard R; Nguyen A; Ullmer L; Hayden J; Lemler S; Weinshilboum RM; Rae JM; Hayes DF; Flockhart DA J Natl Cancer Inst; 2005 Jan; 97(1):30-9. PubMed ID: 15632378 [TBL] [Abstract][Full Text] [Related]
8. Individualization of tamoxifen therapy: much more than just CYP2D6 genotyping. Binkhorst L; Mathijssen RH; Jager A; van Gelder T Cancer Treat Rev; 2015 Mar; 41(3):289-99. PubMed ID: 25618289 [TBL] [Abstract][Full Text] [Related]
9. Characterization of Reference Materials for Genetic Testing of CYP2D6 Alleles: A GeT-RM Collaborative Project. Gaedigk A; Turner A; Everts RE; Scott SA; Aggarwal P; Broeckel U; McMillin GA; Melis R; Boone EC; Pratt VM; Kalman LV J Mol Diagn; 2019 Nov; 21(6):1034-1052. PubMed ID: 31401124 [TBL] [Abstract][Full Text] [Related]
10. Allele Drop Out Conferred by a Frequent CYP2D6 Genetic Variation For Commonly Used CYP2D6*3 Genotyping Assays. Scantamburlo G; Tziolia K; Zopf M; Bernardinelli E; Soyal SM; Civello DA; Vanoni S; Dossena S; Patsch W; Patrinos GP; Paulmichl M; Nofziger C Cell Physiol Biochem; 2017; 43(6):2297-2309. PubMed ID: 29073588 [TBL] [Abstract][Full Text] [Related]
11. Limited predictive value of achieving beneficial plasma (Z)-endoxifen threshold level by CYP2D6 genotyping in tamoxifen-treated Polish women with breast cancer. Hennig EE; Piatkowska M; Karczmarski J; Goryca K; Brewczynska E; Jazwiec R; Kluska A; Omiotek R; Paziewska A; Dadlez M; Ostrowski J BMC Cancer; 2015 Aug; 15():570. PubMed ID: 26232141 [TBL] [Abstract][Full Text] [Related]
12. Stargazer: a software tool for calling star alleles from next-generation sequencing data using CYP2D6 as a model. Lee SB; Wheeler MM; Patterson K; McGee S; Dalton R; Woodahl EL; Gaedigk A; Thummel KE; Nickerson DA Genet Med; 2019 Feb; 21(2):361-372. PubMed ID: 29875422 [TBL] [Abstract][Full Text] [Related]
13. Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment. Borges S; Desta Z; Li L; Skaar TC; Ward BA; Nguyen A; Jin Y; Storniolo AM; Nikoloff DM; Wu L; Hillman G; Hayes DF; Stearns V; Flockhart DA Clin Pharmacol Ther; 2006 Jul; 80(1):61-74. PubMed ID: 16815318 [TBL] [Abstract][Full Text] [Related]
14. Genotype-sensitive reversible and time-dependent CYP2D6 inhibition in human liver microsomes. Storelli F; Desmeules J; Daali Y Basic Clin Pharmacol Toxicol; 2019 Feb; 124(2):170-180. PubMed ID: 30192434 [TBL] [Abstract][Full Text] [Related]
15. Long-Read Single Molecule Real-Time Full Gene Sequencing of Cytochrome P450-2D6. Qiao W; Yang Y; Sebra R; Mendiratta G; Gaedigk A; Desnick RJ; Scott SA Hum Mutat; 2016 Mar; 37(3):315-23. PubMed ID: 26602992 [TBL] [Abstract][Full Text] [Related]
16. Interrogation of CYP2D6 Structural Variant Alleles Improves the Correlation Between CYP2D6 Genotype and CYP2D6-Mediated Metabolic Activity. Dalton R; Lee SB; Claw KG; Prasad B; Phillips BR; Shen DD; Wong LH; Fade M; McDonald MG; Dunham MJ; Fowler DM; Rettie AE; Schuetz E; Thornton TA; Nickerson DA; Gaedigk A; Thummel KE; Woodahl EL Clin Transl Sci; 2020 Jan; 13(1):147-156. PubMed ID: 31536170 [TBL] [Abstract][Full Text] [Related]
17. Accurate determination of the CYP2D6 (*1/*4)xN genotype by quantitative PCR. Pondman KM; van Schaik RHN; van der Weide J Drug Metab Pers Ther; 2018 Mar; 33(1):33-39. PubMed ID: 29420304 [TBL] [Abstract][Full Text] [Related]
18. Novel variant of CYP2D6*6 is undetected by a commonly used genotyping procedure. Rasmussen HB; Werge T Pharmacol Rep; 2011; 63(5):1264-6. PubMed ID: 22180372 [TBL] [Abstract][Full Text] [Related]
19. CYP2D6 genotyping for functional-gene dosage analysis by allele copy number detection. Hosono N; Kato M; Kiyotani K; Mushiroda T; Takata S; Sato H; Amitani H; Tsuchiya Y; Yamazaki K; Tsunoda T; Zembutsu H; Nakamura Y; Kubo M Clin Chem; 2009 Aug; 55(8):1546-54. PubMed ID: 19541866 [TBL] [Abstract][Full Text] [Related]
20. The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels. Opdam FL; Dezentje VO; den Hartigh J; Modak AS; Vree R; Batman E; Smorenburg CH; Nortier JW; Gelderblom H; Guchelaar HJ Cancer Chemother Pharmacol; 2013 Mar; 71(3):593-601. PubMed ID: 23228987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]